Table of Contents
Journal of Amino Acids
Volume 2013 (2013), Article ID 606282, 7 pages
http://dx.doi.org/10.1155/2013/606282
Research Article

Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors

1Dipartimento di Scienze Farmaceutiche e Biomediche, Università degli Studi di Salerno, Via Ponte don Melillo, 84084 Fisciano, Italy
2Dipartimento di Chimica Farmaceutica e Tossicologica, Università degli Studi di Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy
3Dipartimento Farmaco-Biologico, Università degli Studi di Messina, Viale Annunziata, 98168 Messina, Italy
4Dipartimento di Biochimica e Biofisica, Seconda Università degli Studi di Napoli, Via L. De Crecchio 7, 80138 Napoli, Italy
5Dipartimento di Scienze della Salute, Università degli Studi “Magna Græcia” di Catanzaro, Campus Universitario “S. Venuta”, Viale Europa, 88100 Catanzaro, Italy

Received 21 December 2012; Accepted 17 January 2013

Academic Editor: Michele Caraglia

Copyright © 2013 Ermelinda Vernieri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. K. Somvanshi, A. Kumar, S. Kant et al., “Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent,” Biochemical and Biophysical Research Communications, vol. 361, no. 1, pp. 37–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Turini and R. N. DuBois, “CYCLOOXYGENASE-2: a therapeutic target,” Annual Review of Medicine, vol. 53, pp. 35–57, 2002. View at Google Scholar
  3. S. K. Sharma, B. J. Al-Hourani, M. Wuest et al., “Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2),” Bioorganic & Medicinal Chemistry, vol. 20, pp. 2221–2226, 2012. View at Google Scholar
  4. K. Gupta, B. S. Selinsky, C. J. Kaub, A. K. Katz, and P. J. Loll, “The 2.0 Å resolution crystal structure of prostaglandin H 2 synthase-1: structural insights into an unusual peroxidase,” Journal of Molecular Biology, vol. 335, no. 2, pp. 503–518, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. W. Rowlinson, J. R. Kiefer, J. J. Prusakiewicz et al., “A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385,” Journal of Biological Chemistry, vol. 278, no. 46, pp. 45763–45769, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. Schrödinger, LLC., New York, NY, USA, 2010.
  7. T. A. Halgren, “Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF9,” Journal of Computational Chemistry, vol. 17, pp. 490–519, 1996. View at Google Scholar
  8. T. A. Halgren, “Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions,” Journal of Computational Chemistry, vol. 17, pp. 520–552, 1996. View at Google Scholar
  9. T. A. Halgren, “MMFF VI. MMFF94s Option for energy minimization studies,” Journal of Computational Chemistry, vol. 20, pp. 720–729, 1999. View at Google Scholar
  10. T. A. Halgren, “MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries,” Journal of Computational Chemistry, vol. 20, pp. 730–748, 1999. View at Google Scholar
  11. F. Mohamadi, N. G. J. Richards, W. C. Guida et al., “MacroModel-An integrated software system for modeling organic and bioorganic molecules using molecular mechanics,” Journal of Computational Chemistry, vol. 11, pp. 440–467, 1990. View at Google Scholar
  12. E. Atherton and R. C. Sheppard, Solid-Phase Peptide Synthesis: A Practical Approach, IRL, Oxford, UK, 1989.
  13. S. Vilar, E. Quezada, L. Santana et al., “Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 2, pp. 257–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Fioravanti, A. Bolasco, F. Manna et al., “Synthesis and biological evaluation of N-substituted-3, 5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors,” European Journal of Medicinal Chemistry, vol. 45, pp. e6135–e6138, 2010. View at Google Scholar
  15. E. P. Spugnini, G. Citro, and A. Baldi, “Cox inhibitors as potential chemotherapic drugs for mesothelioma,” Current Respiratory Medicine Reviews, vol. 3, no. 1, pp. 15–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. A. Sinicrope, “Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer,” Molecular Carcinogenesis, vol. 45, no. 6, pp. 447–454, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. Méric, S. Rottey, K. Olaussen et al., “Cyclooxygenase-2 as a target for anticancer drug development,” Critical Reviews in Oncology/Hematology, vol. 59, no. 1, pp. 51–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Mazhar, R. Ang, and J. Waxman, “COX inhibitors and breast cancer,” British Journal of Cancer, vol. 94, no. 3, pp. 346–350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ali, B. F. El-Rayes, F. H. Sarkar, and P. A. Philip, “Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy,” Molecular Cancer Therapeutics, vol. 4, no. 12, pp. 1943–1951, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Wu, “Cyclooxygenase-2 in hepatocellular carcinoma,” Cancer Treatment Review, vol. 32, pp. 28–44, 2006. View at Google Scholar
  21. I. Cardillo, E. P. Spugnini, A. Verdina, R. Galati, G. Citro, and A. Baldi, “Cox and mesothelioma: an overview,” Histology and Histopathology, vol. 20, no. 4, pp. 1267–1274, 2005. View at Google Scholar · View at Scopus